US Bancorp DE Trims Stock Holdings in Amedisys, Inc. (NASDAQ:AMED)

US Bancorp DE lessened its position in shares of Amedisys, Inc. (NASDAQ:AMED) by 6.6% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 3,706 shares of the health services provider’s stock after selling 264 shares during the quarter. US Bancorp DE’s holdings in Amedisys were worth $358,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of AMED. BNP Paribas Financial Markets boosted its position in Amedisys by 111.7% in the first quarter. BNP Paribas Financial Markets now owns 12,050 shares of the health services provider’s stock valued at $1,111,000 after buying an additional 6,358 shares during the last quarter. Texas Permanent School Fund Corp boosted its holdings in shares of Amedisys by 1.4% in the 1st quarter. Texas Permanent School Fund Corp now owns 28,560 shares of the health services provider’s stock valued at $2,632,000 after acquiring an additional 381 shares during the last quarter. Swiss National Bank boosted its holdings in shares of Amedisys by 5.4% in the 1st quarter. Swiss National Bank now owns 64,400 shares of the health services provider’s stock valued at $5,935,000 after acquiring an additional 3,300 shares during the last quarter. State Board of Administration of Florida Retirement System increased its stake in shares of Amedisys by 5.3% in the first quarter. State Board of Administration of Florida Retirement System now owns 38,403 shares of the health services provider’s stock worth $3,539,000 after acquiring an additional 1,923 shares during the period. Finally, Covestor Ltd raised its holdings in shares of Amedisys by 134.2% during the first quarter. Covestor Ltd now owns 780 shares of the health services provider’s stock worth $72,000 after purchasing an additional 447 shares during the last quarter. 94.36% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

AMED has been the topic of several analyst reports. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $101.00 price target on shares of Amedisys in a research report on Thursday, July 25th. Deutsche Bank Aktiengesellschaft lowered Amedisys from a “buy” rating to a “hold” rating and set a $101.00 target price on the stock. in a report on Monday, July 29th. Four research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat.com, Amedisys currently has an average rating of “Hold” and a consensus price target of $100.67.

Amedisys Trading Down 1.8 %

Shares of Amedisys stock opened at $91.00 on Wednesday. The firm has a 50-day simple moving average of $96.46 and a two-hundred day simple moving average of $95.89. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.16 and a current ratio of 1.19. Amedisys, Inc. has a fifty-two week low of $89.55 and a fifty-two week high of $98.95. The company has a market cap of $2.98 billion, a P/E ratio of 36.11, a price-to-earnings-growth ratio of 1.90 and a beta of 0.78.

Amedisys (NASDAQ:AMED) last released its quarterly earnings results on Wednesday, November 6th. The health services provider reported $1.00 earnings per share for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.19). Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The business had revenue of $587.67 million during the quarter, compared to analyst estimates of $586.75 million. During the same period in the previous year, the company posted $0.98 EPS. The business’s revenue for the quarter was up 5.7% compared to the same quarter last year. As a group, equities analysts predict that Amedisys, Inc. will post 4.62 earnings per share for the current fiscal year.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.